PD-1/PD-L1 Inhibitors versus Chemotherapy for Previously Treated Advanced Gastroesophageal Cancer: A Meta-Analysis of Randomized Controlled Trials

Figure 4

Meta-analysis results of progression-free survival (PFS) between the PD-1/PD-L1 inhibitor group and chemotherapy group.